TransCytos, LLC.

TransCytos offers novel fluid dynamics based instruments for transfection of all cell types - a key step for disease research, drug discovery, and human therapy

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Southbridge, MA, US
  • Currency USD
  • Founded March 2010
  • Employees 1

Company Summary

TransCytos offers a faster path to drug discovery and better cures for cancer, and heart and neuronal diseases through gentle introduction of genetic material into living cells. Our user-friendly instruments and consumables follow the razor – razor blade model. Our business is effective and cost efficient: we work closely with our future customers, and experts, companies, and labs in the development of processes and the production of our products

Team

  • Otto Prohaska
    President and CEO

    Expert in the commercialization of inventions and the formation of cost-efficient, high growth and ROI focused enterprises through closely collaborating customer – expert – industry partner – investor teams. Moved from “inventor” to “company-internal investor” positions in academia, and small and large corporations. Obtained his Ph.D. in Applied Physics, University of Technology, Vienna, Austria and his Executive MBA, University of Connecticut.

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free